Shifting supply chains, infant formula under scrutiny, lunar mission: Catch up on the day's stories
Here's what else you might have missed during your busy day:
1️⃣ 'We need to change': With President Donald Trump enacting tariffs on nearly every US import, American companies are scrambling to move their supply chains out of countries like Mexico and China. This small island in the Caribbean could be the answer.
2️⃣ Builders of peace: Congregation Bonai Shalom in Boulder, Colorado, welcomes both Jews and non-Jews to participate in all aspects of the community. An antisemitic attack that injured several members — including a Holocaust survivor — is testing their resilience.
3️⃣ Tracking measles: As cases rise to precipitously high levels in the US, there's a new tool to help measure the spread of the disease. Wastewater surveillance has the potential to identify possible cases days before an individual shows symptoms or seeks care.
4️⃣ Lunar lander: A Japanese company will try to touch down on the moon three months after an uncrewed American spacecraft did the same. Ispace executives said their slow and steady approach offers some long-term advantages.
5️⃣ Candid confession: Kylie Jenner detailed her breast augmentation on TikTok — down to the exact size. Her revelation chips away at a taboo. But is it a victory for transparency or a setback for beauty standards?
GET '5 THINGS' IN YOUR INBOX
CNN's 5 Things newsletter is your one-stop shop for the latest headlines and fascinating stories to start and end your busy day. Sign up here. ☔ Waterlogged: Flash flood emergencies were declared in Wichita and El Dorado, Kansas, after a month's worth of rain fell in one day. The heavy rain flooded roads and submerged cars.
• Trump says Putin told him in phone call he will respond to Ukraine's weekend drone attacks• 2 Chinese researchers charged with smuggling biological pathogen to study at university lab• US Education Department threatens Columbia University's accreditation over campus antisemitism concerns
💸 That's how much House Republicans' sweeping tax and spending cuts package would add to the deficit over the next decade, according to a Congressional Budget Office analysis.
🪨 Preserving history: Stephen Townley Bassett is painstakingly recreating mysterious ancient rock art in South Africa before it's lost. His works are no ordinary replicas.
I'm not going to be a part of Trump's lying.
Pam Hemphill
💬 No thanks: Formerly known as 'MAGA Granny,' Hemphill is a convicted January 6 rioter who served two months in federal prison. Watch as she explains why she refused a pardon from President Trump.
🪖 Approximately how many Russian soldiers have been killed or injured in the war with Ukraine?A. 100,000B. 300,000C. 600,000D. 950,000⬇️ Scroll down for the answer.
🎾 C'est magnifique! Heavy underdog Lois Boisson continued her fairy tale run at the French Open tennis tournament by beating No. 6 seed Mirra Andreeva to advance to the semifinals. The hometown hero's next opponent? American Coco Gauff.
👋 We'll see you tomorrow.🧠 Quiz answer: D. Russia is nearing 1 million war casualties in Ukraine.📧 Check out all of CNN's newsletters.
5 Things PM is produced by CNN's Chris Good, Meghan Pryce, Kimberly Richardson and Morgan Severson.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
TMO Receives FDA Approval for Oncomine Dx Target Test
Thermo Fisher Scientific TMO recently received approval from the Food and Drug Administration ('FDA') for its Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients who may be candidates for HERNEXEOS (zongertinib tablets), a tyrosine kinase inhibitor (TKI). The HERNEXEOS, developed by Boehringer Ingelheim, is the first and only FDA-approved orally administered targeted therapy for adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC). The recent approval is expected to bolster Thermo Fisher's Specialty Diagnostics arm. About TMO's Oncomine Dx Target Test The Oncomine Dx Target Test checks if NSCLC tumors harbor human epidermal growth factor receptor 2 (HER2/ERBB2) tyrosine kinase domain (TKD) activating mutations. It enables multi-biomarker analysis from a single tissue sample to aid treatment decisions in as little as four days. This reduces the need for second biopsies and avoids suboptimal therapy selection in the absence of a complete biomarker report. The test is fully reimbursed by Medicare, as well as by the top 20 commercial payers in the United States. Oncomine Dx Target Test's Global Approvals The Oncomine Dx Target Test received its first approval by the FDA as an NGS CDx in 2017, followed by regulatory approvals in 20 countries for 11 biomarkers and over 20 targeted therapies. The test is reimbursed by government and commercial insurers in the United States, Europe, Japan, South Korea and Israel, covering more than 550 million lives globally. In the United States alone, it is approved for targeted therapies in NSCLC, cholangiocarcinoma (CC), astrocytoma (AC) and oligodendroglioma (OG), anaplastic thyroid cancer (ATC), medullary thyroid cancer (MTC) and thyroid cancer (TC). Industry Prospects Favor TMO According to the American Cancer Society, lung cancer is the second most common cancer in both men and women in the United States, with NSCLC accounting for about 85-90% of all lung cancer cases. Research further indicates that roughly 2-4% of NSCLC patients carry a HER2 mutation. With lung cancer cases continuing to rise, the global market for NSCLC treatments is expected to expand significantly, reaching $66.04 billion by 2032 at a CAGR of 10.3% from 2024 to 2032 (per Fortune Business Insights). Another Development by TMO Thermo Fisher recently announced the FDA approval for Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for Dizal's ZEGFROVY (sunvozertinib) and in tumor profiling. Offerings by TMO's Competitors In the oncology space, Thermo Fisher faces competition from some prominent MedTech players. These companies are also making notable developments in their respective businesses. An expanding NGS oncology portfolio is helping Illumina ILMN drive the revolution in cancer genomics. The company's market-leading TruSight Oncology assay, TSO 500, continues to see increased utilization and broader adoption. In February, the company announced a new single-cell offering for CRISPR research with applications in oncology, immunology and drug target discovery. In 2024, the FDA approved its in vitro diagnostic (IVD) TSO Comprehensive test and its first two companion diagnostic (CDx) indications to rapidly match patients to targeted therapies. This year, Illumina is set to roll out TSO 500 v2, a new version that includes hundreds of genes across all variant classes and immuno-oncology biomarkers in a single assay from one sample, to facilitate therapy selection research. A rapidly expanding liquid biopsy and NGS-based testing portfolio is positioning Guardant Health GH as a leader in precision oncology. The company's flagship Guardant360 test has been recently enhanced with the Guardant Infinity platform, enabling a single blood draw to provide comprehensive tumor profiling, confirm the absence of actionable mutations and determine ER/PR/HER2 status. Regulatory milestones include approvals for Guardant360 CDx as a companion diagnostic in the United States, Japan and Singapore, covering multiple cancer targets such as EGFR and HER2 mutations. Its pipeline also includes the FDA-approved Shield blood test for colorectal cancer screening, offering a non-invasive alternative to colonoscopy. Exact Sciences' EXAS flagship screening product, the Cologuard test, is a non-invasive, stool-based DNA (sDNA) screening test that utilizes a multitarget approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company's precision oncology portfolio also offers the Oncotype DX Breast Recurrence Score test to identify patients who are most likely to benefit from chemotherapy, as well as those who may receive no clinical benefit from chemotherapy. Its Oncotype DX Colon Recurrence Score test is a multi-gene test for predicting recurrence risk in patients with stage II and stage III A/B colon cancer to enable an individualized approach to treatment planning. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report Illumina, Inc. (ILMN) : Free Stock Analysis Report Exact Sciences Corporation (EXAS) : Free Stock Analysis Report Guardant Health, Inc. (GH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Epoch Times
13 minutes ago
- Epoch Times
FDA Advises Americans Against ‘Mousse' Sunscreens, Warns 5 Manufacturers
Americans should 'beware' of sunscreen products in mousse form as they may not be effective, the Food and Drug Administration (FDA) said in an Aug. 12 X post, with the agency sending warning letters to five companies marketing sunscreen products. The letters were sent on Aug. 6 to Texas-based Supergoop, Pennsylvania-based Fallien Cosmeceuticals Ltd., Israel-based K & Care Organics, Sweden-based Kalani AB, and Florida-based Vacation Inc.
Yahoo
27 minutes ago
- Yahoo
What Happens to Your Cholesterol When You Walk Every Day
Reviewed by Dietitian Maria Laura Haddad-Garcia Key Points Walking daily is one of the simplest low-barrier ways to support your overall heart health. Walking may help lower your LDL cholesterol and triglyceride levels and raise HDL cholesterol levels. Using weights, tracking your steps and walking post-meal are ways to make walking more effective. Trying to lower your cholesterol and support your heart health without hitting the gym? The good news is that you don't need a grueling fitness routine to make a difference in your cardiovascular health. Walking every day is a simple and accessible habit that can help improve your blood lipids (triglycerides, LDL or 'bad' and HDL or 'good' cholesterol levels) and protect your cardiovascular system in the long run. Why does this matter? 'High cholesterol is a major modifiable risk factor for the development of coronary artery disease,' says Bradley Serwer, M.D. 'By managing your cholesterol levels, you can potentially avoid or minimize heart attacks, strokes or peripheral vascular disease.' Your triglyceride levels are important, too. High triglycerides can happen on their own, but they can also go hand-in-hand with cholesterol levels, increasing your risk for heart disease. The Benefits of Walking for Cholesterol Daily walking delivers a range of benefits for cholesterol management and heart health. Here's an in-depth look at how it works. Lowers LDL Cholesterol When we talk about 'bad' cholesterol, we're referring to low-density lipoproteins or LDL, a waxy substance that can build up in your arteries. 'Elevated LDL increases the risk of heart attack and stroke by promoting plaque in critical vessels, particularly those of the heart and brain,' explains Alan Rozanski, M.D.. Research shows that for women with overweight or obesity, walking regularly for at least four weeks slightly lowers total cholesterol and 'bad' LDL cholesterol by about 7 mg/dL. Another study conducted on men found that consistent, moderate exercise for 12 weeks reduced LDL cholesterol by 5% to 7%. At the same time, more research on both men and women, ages 40 to 65, found that walking for three months or more produced mixed results, with some studies finding changes in cholesterol and triglyceride levels while others did not. While the effects may vary, incorporating regular walking into your routine is a simple and accessible way to support overall heart health. Supports Healthy HDL Cholesterol High-density lipoprotein (HDL) is often called the 'good' cholesterol because it removes cholesterol, protects against harmful oxidation, reduces inflammation and may help prevent blood clots. Higher levels of HDL are linked to lower risks of heart disease according to some (but not all) data. 'Aerobic activities such as walking help raise your high-density lipoprotein, HDL,' shares Serwer. Research shows that beyond just changing the numbers, exercise helps HDL particles mature and function better. Helps Lower Triglycerides Triglycerides are a type of fat in your blood, and elevated levels are another risk factor for cardiovascular disease. The good news? Walking is an effective way to lower them. During physical activity, your muscles use triglycerides as an energy source. Participating in physical activity, like walking, has been linked to reduced triglyceride concentrations in some studies. Supports Better Weight Management Walking is one of the simplest and most effective ways to support weight loss. It burns calories, supports metabolism and helps maintain lean muscle mass, all of which contribute to shedding extra pounds. Plus, it's an accessible and low-impact activity that can be easily incorporated into daily routines, making it a sustainable choice for long-term weight management. Carrying excess weight is closely linked to a range of heart-health concerns, including high cholesterol levels. People who carry extra body fat, particularly around the abdomen, tend to have higher LDL cholesterol levels. By making walking a regular habit, you can take a proactive step toward managing your weight and protecting your heart health. Helps Spark a Positive Feedback Loop Walking can also inspire a ripple effect of healthier choices. 'Walking can spark a positive feedback loop. As people become more active, they tend to feel better and adopt healthier habits—like improved eating—which further supports cholesterol management. That's why doctors often encourage movement as a starting point for lifestyle change,' explains Rozanski. This initial step toward activity often lays the groundwork for broader lifestyle improvements. By supporting energy levels and possibly improving mood, walking can make it easier to embrace other heart-healthy habits. Whether it's preparing more nutritious meals, getting better sleep or feeling motivated to try new activities, these changes work together to enhance overall health. Walking, therefore, isn't just exercise; it can be a catalyst for long-term, positive transformation. How Much Walking Do You Need? The Centers for Disease Control and Prevention recommends at least 150 minutes of moderate-intensity physical activity per week, which breaks down to about 30 minutes a day, five days a week. Brisk walking (about 3 to 4 miles per hour) fits the bill perfectly. If possible, aim for even more; 300 minutes weekly is linked to even greater heart benefits. 'But for the 25% of people who get no exercise at all, that can feel out of reach. The encouraging news is that even short bouts—like brisk five-minute walks—canimprove health,' says Rozanski. If you want to maximize results, adding some intensity can help. Try integrating inclines, walking at a faster pace, or even intervals where you alternate between slow and brisk walking. Tips to Make Walking Work for You Walking is simple, but a few tweaks can make it even more effective. Here are practical tips to make your daily walks count: Walk after meals to help with lipid metabolism. A 10- to 15-minute walk after eating can aid digestion and improve cholesterol processing. Add inclines or use hand weights for added cardio benefits. Walking uphill or using light weights engages more muscles and burns more fat. Track your steps with a pedometer or app to stay accountable and motivated. Many people find the goal of 10,000 steps a day achievable and rewarding. Pair your walking with . Start your day with oatmeal or snack on walnuts post-walk to double down on heart-health benefits. Small changes compound over time, so feel free to adjust these tips to your routine. Our Expert Take It's official! Walking daily is one of the simplest low-barrier ways to support your overall heart health. It's easy to incorporate into your lifestyle, whether that's a morning stroll, a post-dinner walk or active errands around town. Remember, you don't need fancy equipment, a big time commitment or extreme workouts. All it takes is lacing up your shoes and stepping outdoors. Starting small (like a 10-minute daily walk) can lead to big results over time. Your heart doesn't care how fast you go, just that you keep going. The sooner you start, the sooner your body and mind will feel the benefits. Take that first step today; your heart will thank you tomorrow. Read the original article on EATINGWELL
